Global Tumor Marker Diagnostic Market 2016: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities

Nov 23, 2015, 07:10 ET from Research and Markets

DUBLIN, Nov. 23, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zwjgnk/2016_global_tumor) has announced the addition of the "2016 Global Tumor Marker Diagnostic Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering.

This new report provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Company Assessments

- Abbott

- Applied Gene Technologies

- Becton Dickinson

- Decode Genetics

- Diadexus

- Diagnocure

- Diasorin

- Eiken Chemical

- Elitech Group

- Epigenomics

- Enzo Biochem

- Exact Sciences

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher

- Tosoh

- Veridex

- Wako Pure Chemicals

- Zila

For more information visit http://www.researchandmarkets.com/research/zwjgnk/2016_global_tumor

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com